Press Releases

All Releases
View Summary Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update
Feb 21, 2012
PDF 20.1 KB Add to Briefcase
View Summary Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call
Feb 9, 2012
PDF 10.0 KB Add to Briefcase
View Summary Anthera Announces Completion of Safety Review by DSMB for VISTA-16
Dec 14, 2011
PDF 11.5 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer
Dec 5, 2011
PDF 11.4 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study
Dec 1, 2011
PDF 13.2 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update
Nov 1, 2011
PDF 20.1 KB Add to Briefcase
View Summary Anthera Announces Last Patient Enrolled in PEARL-SC Study
Oct 25, 2011
PDF 13.8 KB Add to Briefcase
View Summary Anthera Announces Third Quarter 2011 Financial Report and Conference Call
Oct 24, 2011
PDF 10.0 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions
Sep 8, 2011
PDF 12.5 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
Jul 29, 2011
PDF 18.9 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
Jun 8, 2011
PDF 12.1 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jun 3, 2011
PDF 12.3 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jun 2, 2011
PDF 12.0 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
May 3, 2011
PDF 18.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
Apr 18, 2011
PDF 14.9 KB Add to Briefcase
View Summary Anthera Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference
Feb 24, 2011
PDF 9.9 KB Add to Briefcase
View Summary Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
Feb 23, 2011
PDF 10.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results and Operational Update
Feb 23, 2011
PDF 20.5 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
Feb 8, 2011
PDF 12.0 KB Add to Briefcase
View Summary Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
Feb 1, 2011
PDF 11.4 KB Add to Briefcase
Showing 1-20 of 75 Page: 1 2 3 4  Next 20
=add release to Briefcase
Back to Top